日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIII

TAK-754 的临床前开发,TAK-754 是一种基于 AAV8 的高性能载体,可表达凝血因子 VIII

Lengler, Johannes; Weiller, Markus; Horling, Franziska; Mayrhofer, Josef; Schuster, Maria; Falkner, Falko G; Gil-Farina, Irene; Klugmann, Matthias; Scheiflinger, Friedrich; Hoellriegl, Werner; Rottensteiner, Hanspeter

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease

重组ADAMTS13在人源化镰状细胞病模型中的保护作用证据

Rossato, Paolo; Federti, Enrica; Matte, Alessandro; Glantschnig, Helmut; Canneva, Fabio; Schuster, Maria; Coulibaly, Sogue; Schrenk, Gerald; Voelkel, Dirk; Dockal, Michael; Plaimauer, Barbara; Andolfo, Immacolata; Iolascon, Achille; Rottensteiner, Hanspeter; Gritsch, Herbert; Scheiflinger, Friedrich; Hoellriegl, Werner; Franceschi, Lucia De

Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey

重组ADAMTS13在大鼠和猴子中未表现出过度药理作用

Rossato, Paolo; Glantschnig, Helmut; Leidenmühler, Peter; Kopic, Alexandra; Ruthsatz, Tanja; Majer, Bernhard; Schuster, Maria; Scheiflinger, Friedrich; Höllriegl, Werner

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

BAX 335 B型血友病基因治疗临床试验结果:CpG序列对基因表达的潜在影响

Konkle, Barbara A; Walsh, Christopher E; Escobar, Miguel A; Josephson, Neil C; Young, Guy; von Drygalski, Annette; McPhee, Scott W J; Samulski, R Jude; Bilic, Ivan; de la Rosa, Maurus; Reipert, Birgit M; Rottensteiner, Hanspeter; Scheiflinger, Friedrich; Chapin, John C; Ewenstein, Bruce; Monahan, Paul E

Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors

阻断共刺激CD28-B7家族信号轴可实现AAV8基因载体的重复应用

Frentsch, Marco; Japp, Alberto Sada; Dingeldey, Manuela; Matzmohr, Nadine; Thiel, Andreas; Scheiflinger, Friedrich; Reipert, Birgit M; de la Rosa, Maurus

Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release

开发适用于临床产品上市的AAV8血友病B基因治疗载体的体外生物活性检测方法

Lengler, Johannes; Coulibaly, Sogue; Gruber, Bernadette; Ilk, Reinhard; Mayrhofer, Josef; Scheiflinger, Friedrich; Hoellriegl, Werner; Falkner, Falko G; Rottensteiner, Hanspeter

Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency

最小必需人凝血因子VIII改变可增强分泌和基因治疗效率

Cao, Wenjing; Dong, Biao; Horling, Franziska; Firrman, Jenni A; Lengler, Johannes; Klugmann, Matthias; de la Rosa, Maurus; Wu, Wenman; Wang, Qizhao; Wei, Hongying; Moore, Andrea R; Roberts, Sean A; Booth, Carmen J; Hoellriegl, Werner; Li, Dong; Konkle, Barbara; Miao, Carol; Reipert, Birgit M; Scheiflinger, Friedrich; Rottensteiner, Hanspeter; Xiao, Weidong

Temperature-dependent irreversible conformational change of recombinant ADAMTS13 upon metal ion chelation

金属离子螯合后重组ADAMTS13的温度依赖性不可逆构象变化

Rottensteiner, Hanspeter; Kaufmann, Stefan; Rathgeb, Anna; Kink, Barbara; Plaimauer, Barbara; Matthiessen, Peter; Hann, Stephan; Scheiflinger, Friedrich

Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.

在 ADAMTS13 中鉴定出半胱氨酸硫醇基连接,支持对血管性血友病因子进行非蛋白水解调节

Rottensteiner Hanspeter, Seyfried Birgit K, Kaufmann Stefan, Fiedler Christian, Dong Jing-Fei, Zheng X Long, Plaimauer Barbara, Scheiflinger Friedrich

How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain

全长FVIII如何从其异质性中获益——B结构域作用机制研究

Anzengruber, Julia; Feichtinger, Martin; Bärnthaler, Philipp; Haider, Norbert; Ilas, Josenato; Pruckner, Nina; Benamara, Karima; Scheiflinger, Friedrich; Reipert, Birgit M; Malisauskas, Mantas